PARP-14 inhibitors constitute a diverse group of organic compounds characterized by their distinct ability to selectively modulate the activity of Poly(ADP-ribose) polymerase 14 (PARP-14). PARP-14 is an enzyme that plays a pivotal role in cellular processes by catalyzing the attachment of ADP-ribose units to target proteins, thereby influencing various molecular pathways. PARP-14 inhibitors exert their effects by interacting with specific binding sites associated with the PARP-14 enzyme, thus influencing its catalytic activity and downstream cellular responses. These inhibitors are designed to impose a regulatory influence on PARP-14-associated post-translational modifications, contributing to the modulation of intricate cellular dynamics.
The chemical structures of PARP-14 inhibitors encompass a wide array of molecular arrangements, and ongoing scientific research endeavors seek to decipher their precise mechanisms of action. As scientists continue to explore the intricate roles of PARP-14 in cellular processes, inhibitors targeting this enzyme provide valuable tools for unraveling the complex interplay of molecular events underlying various physiological and pathological conditions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
3-Aminobenzamide | 3544-24-9 | sc-3501 sc-3501B sc-3501A | 100 mg 1 g 5 g | $15.00 $37.00 $52.00 | 18 | |
3-AB is a classical PARP inhibitor that has been used to study the functions of various PARP enzymes, including PARP-14. | ||||||
PARP Inhibitor VIII, PJ34 | 344458-15-7 | sc-204161 sc-204161A | 1 mg 5 mg | $58.00 $142.00 | 20 | |
PJ34 is a potent PARP inhibitor that has been investigated for its effects on DNA damage response pathways, which are mediated by PARP enzymes like PARP-14. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is an approved PARP inhibitor primarily used for certain cancers, but it also inhibits other PARP enzymes like PARP-14. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $182.00 $275.00 $726.00 | 3 | |
Veliparib is another PARP inhibitor that has been explored for its potential applications and effects on various PARP family members. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Rucaparib is an inhibitor of several PARP enzymes, including PARP-14, and has been investigated for its role in cancer therapy. | ||||||
Talazoparib | 1207456-01-6 | sc-507440 | 10 mg | $795.00 | ||
Talazoparib is a PARP inhibitor with a high potency against various PARP family members, including PARP-14. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
Niraparib is a PARP inhibitor investigated for certain cancers, and it has demonstrated activity against various PARP family members, including PARP-14. | ||||||